Clinical Trial Update: Memory-enriched CAR-T Cells Immunotherapy for B Cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating memory-enriched CAR-T cell therapy for various recurrent B cell lymphomas, including diffuse large B cell lymphoma and fol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• Mantle Cell Lymphoma

Drugs mentioned

• Memory-enriched CAR-T cells immunotherapy

Snippet

Sponsor: Xinqiao Hospital of Chongqing | Conditions: Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Follicular Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN